Skip to content

Clinical Study of Sanqihuogutang Modified combine with Extracorporeal Shock Wave on Patients with early Avascular Necrosis of Femoral Head with Qi-Blood Stagnation type

Clinical Study of Sanqihuogutang Modified on Patients with early Avascular Necrosis of Femoral Head with Qi-Blood Stagnation type

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005784
Enrollment
Unknown
Registered
2022-03-29
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of Femur Head

Interventions

2:Sanqihuogutang Modified combine with Extracorporeal Shock Wave
1:External shock wave therapy

Sponsors

The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? The patients met the clinical diagnostic criteria of femoral head necrosis; ?ARCO stages were stage I and II, conforming to traditional Chinese medicine syndrome of qi stagnation and blood stasis; ? Patients aged between 20 and 70 years old with no gender limitation; (4) Patients with stable condition and clear expression ability; (5) Patients and their families can actively cooperate to complete the clinical observer; ? Those who have not received other drugs or other treatment within 1 week; ?VAS pain score ranged from 3 to 8.

Exclusion criteria

Exclusion criteria: ? The patients who do not meet the diagnostic criteria and inclusion criteria; ? Patients with cognitive impairment and impaired expression; ? Patients with congenital hip dysplasia or suppurative hip infection caused by ANFH patients; ? Patients with serious heart and cerebrovascular diseases or serious blood system diseases; ?Immune system diseases such as rheumatoid arthritis, ankylosing spondylitis and other drugs caused by ONFH patients; ? The physical condition is very poor, severe anemia; Not according to the treatment plan or take other drugs during the treatment; (8) VAS pain score less than 3 points or more than 8 points; ? Persons who took hormone therapy for other special diseases during treatment.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale of pain;TCM qi-stagnation and blood-stasis syndrome score;Harris hip score;

Countries

China

Contacts

Public ContactZhigang Li

The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

zhigangli20211101@163.com13836034781

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026